Decomposition of the Total Effect in the Presence of Multiple Mediators and Interactions

被引:45
作者
Bellavia, Andrea [1 ,2 ]
Valeri, Linda [3 ,4 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[3] Harvard Med Sch, Dept Psychiat, Boston, MA USA
[4] McLean Hosp, Psychiat Biostat Lab, Belmont Campus North Belknap,Room 310A, Belmont, MA 02478 USA
基金
美国国家卫生研究院;
关键词
causal inference; effect decomposition; interaction; mediation; SENSITIVITY-ANALYSIS; SCHIZOPHRENIA TRIAL; ANTIPSYCHOTIC-DRUGS;
D O I
10.1093/aje/kwx355
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Mediation analysis allows decomposing a total effect into a direct effect of the exposure on the outcome and an indirect effect operating through a number of possible hypothesized pathways. Recent studies have provided formal definitions of direct and indirect effects when multiple mediators are of interest and have described parametric and semiparametric methods for their estimation. Investigating direct and indirect effects with multiple mediators, however, can be challenging in the presence of multiple exposure-mediator and mediator-mediator interactions. In this paper we derive a decomposition of the total effect that unifies mediation and interaction when multiple mediators are present. We illustrate the properties of the proposed framework in a secondary analysis of a pragmatic trial for the treatment of schizophrenia. The decomposition is employed to investigate the interplay of side effects and psychiatric symptoms in explaining the effect of antipsychotic medication on quality of life in schizophrenia patients. Our result offers a valuable tool to identify the proportions of total effect due to mediation and interaction when more than one mediator is present, providing the finest decomposition of the total effect that unifies multiple mediators and interactions.
引用
收藏
页码:1311 / 1318
页数:8
相关论文
共 24 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[3]   Causal Mediation Analysis with Multiple Mediators [J].
Daniel, R. M. ;
De Stavola, B. L. ;
Cousens, S. N. ;
Vansteelandt, S. .
BIOMETRICS, 2015, 71 (01) :1-14
[4]  
Davis JM, 2009, PSYCHIAT SERV, V60, P125, DOI 10.1176/appi.ps.60.1.125-a
[5]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276
[6]   Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis [J].
Leucht, Stefan ;
Cipriani, Andrea ;
Spineli, Loukia ;
Mavridis, Dimitris ;
Oerey, Deniz ;
Richter, Franziska ;
Samara, Myrto ;
Barbui, Corrado ;
Engel, Rolf R. ;
Geddes, John R. ;
Kissling, Werner ;
Stapf, Marko Paul ;
Laessig, Bettina ;
Salanti, Georgia ;
Davis, John M. .
LANCET, 2013, 382 (9896) :951-962
[7]   Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].
Lieberman, JA ;
Stroup, TS ;
McEvoy, JP ;
Swartz, MS ;
Rosenheck, RA ;
Perkins, DO ;
Keefe, RSE ;
Davis, SM ;
Davis, CE ;
Lebowitz, BD ;
Severe, J ;
Hsiao, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223
[8]   Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 [J].
Meyer, Jonathan M. ;
Davis, Vicki G. ;
Goff, Donald C. ;
McEvoy, Joseph P. ;
Nasrallah, Henry A. ;
Davis, Sonia M. ;
Rosenheck, Robert A. ;
Daumit, Gail L. ;
Hsiao, John ;
Swartz, Marvin S. ;
Stroup, T. Scott ;
Lieberman, Jeffrey A. .
SCHIZOPHRENIA RESEARCH, 2008, 101 (1-3) :273-286
[9]   Causality: Models, reasoning, and inference [J].
Neuberg, LG .
ECONOMETRIC THEORY, 2003, 19 (04) :675-685
[10]  
Pearl J., 2001, P 17 C UNCERTAINTY A, P411, DOI DOI 10.5555/2074022.2074073